Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00704 |
| Species: | Homo sapiens |
| Position : | chr9:21980404-21981404 |
| Year: | 2023 |
| Title: | Identification and functional validation of an enhancer variant in the 9p213 locus associated with glaucoma risk and elevated expression of p16INK4a |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cervical cancer |
| PMID: | 37345431 |
| MONDO: | MONDO:0001156 |
| Tissue: | Cervix |
| Tissue Ontology ID: | UBERON:0000002 |
| Cell Source: | HeLa |
| CVCL ID: | CVCL_0030 |
| Cell Type: | cervical adenocarcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase Reporter Assay, EMSA, ChIP-RT-qPCR, RT-RT-qPCR |
| Target gene : | CDKN2A |
| TF name : | YY1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| YY1 | Activation of anterior HOX genes in hindbrain development during early embryogenesis | reactome | 120 |
| YY1 | DNA Damage Recognition in GG-NER | reactome | 38 |
| YY1 | E2F transcription factor network | pid | 77 |
| YY1 | mTOR signaling pathway | pid | 66 |
| YY1 | Notch-mediated HES/HEY network | pid | 48 |
| YY1 | Notch | netpath | 76 |
| YY1 | Notch signaling pathway | pid | 58 |
| YY1 | p53 pathway | pid | 59 |
| YY1 | Signaling events mediated by HDAC Class I | pid | 89 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01222 | chr9:21978000-21983000 | Lung | fetal lung fibroblast | -- |
| E_00703 | chr9:21980404-21981404 | Brain | neural stem cell | -- |
| E_00705 | chr9:21980404-21981404 | Lung | fetal lung fibroblast | -- |
| E_00706 | chr9:21980404-21981404 | Breast | breast carcinoma cell | breast carcinoma |
| E_00707 | chr9:21980404-21981404 | Embryonic Kidney | embryonic kidney cell | -- |